DIP
CRVO icon

DT Investment Partners’s CervoMed CRVO Stock Holding History

DT Investment Partners’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-142
Closed -$2.07K – 571
2024
Q3 		$2.07K Buy
+142
New +$2.2K ﹤0.01% 602

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

DT Investment Partners's CRVO Position: Q4 2024 in Review

DT Investment Partners sold out of CervoMed (CRVO) in Q4 2024, closing a stake of 142 shares — an estimated $2.07K sold.

DT Investment Partners first reported a position in CRVO in Q3 2024 and held it in 1 quarter. The position peaked at $2.07K in Q3 2024. 49 funds tracked by Wall St. Rank hold CRVO as of Q4 2024.

  • DT Investment Partners reported no remaining CervoMed position as of Q4 2024 after selling out during the quarter.
  • DT Investment Partners sold 142 CervoMed shares in Q4 2024, an estimated $2.07K.
  • DT Investment Partners first reported a position in CervoMed in Q3 2024 and held it in 1 quarter.
  • DT Investment Partners's CervoMed position peaked at $2.07K in Q3 2024.
  • 49 funds tracked by Wall St. Rank held CervoMed as of Q4 2024.

Based on DT Investment Partners's 13F filing for Q4 2024, filed 30 Jan 2025.